Drug Side Effects
Search
KAPOSI SARCOMA INFLAMMATORY CYTOKINE SYNDROME
KAPOSI SARCOMA INFLAMMATORY CYTOKINE SYNDROME
was reported 59 times
KAPOSI SARCOMA INFLAMMATORY CYTOKINE SYNDROME is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Selective T Cell Costimulation Blocker [EPC]
7
0.0015
1
Cytomegalovirus pUL97 Kinase Inhibitor [EPC]
3
0.0012
2
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
12
0.0005
3
Antimetabolite Immunosuppressant [EPC]
6
0.0003
4
Protease Inhibitor [EPC]
5
0.0001
5
CD19-directed Chimeric Antigen Receptor [EPC]
1
0.0001
6
Cytochrome P450 3A Inhibitor [EPC]
5
0.0001
7
Nucleoside Analog Antiviral [EPC]
7
0.0001
8
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
7
0.0001
9
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
5
0.0001
10
Calcineurin Inhibitor Immunosuppressant [EPC]
6
0.0000
11
Kinase Inhibitor [EPC]
18
0.0000
12
Azole Antifungal [EPC]
5
0.0000
13
Janus Kinase Inhibitor [EPC]
5
0.0000
14
Interleukin-6 Receptor Antagonist [EPC]
4
0.0000
15
CD20-directed Cytolytic Antibody [EPC]
8
0.0000
16
Corticosteroid [EPC]
31
0.0000
17
Alkylating Drug [EPC]
5
0.0000
18
Nitroimidazole Antimicrobial [EPC]
1
0.0000
19
Tetracycline-class Drug [EPC]
1
0.0000
20
Folate Analog Metabolic Inhibitor [EPC]
5
0.0000
21
Nucleoside Metabolic Inhibitor [EPC]
1
0.0000
22
Tumor Necrosis Factor Blocker [EPC]
1
0.0000